About LODESTONE BIOMEDICAL INC.
Lodestone Biomedical is a company focused on accelerating cancer research through innovative tools for real-time monitoring of immune responses in the tumor microenvironment. Their Immune Response Indication System (IRIS) enables early-stage drug discovery and development with greater speed and confidence.
Real-time monitoring of immune system response in the tumor microenvironmentBiosensing and monitoring of the tumor microenvironment in research models of cancerQuantitative detection of cytokines or chemokinesHot/cold tumor baseline measurementMonitoring efficacy of neoadjuvant therapyDose response optimizationPatient stratificationDetection of apoptosis markers
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC 405: INTRATUMORAL BIOSENSING FOR IN VIVO PHARMACOTYPING | Department of Health and Human Services | $2.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LODESTONE BIOMEDICAL INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.